+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2024 Update

  • PDF Icon

    Company Profile

  • 93 Pages
  • May 2024
  • GlobalData
  • AngioDynamics
  • ID: 5726064
AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. It sells its products through direct sales force in the US and through a network of distributors outside the US, which include Latin America Europe, Asia, and others. AngioDynamics is headquartered in Latham, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AngioDynamics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • AngioDynamics Inc Company Overview
  • AngioDynamics Inc Company Snapshot
  • AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AngioDynamics Inc - Pipeline Analysis Overview
  • Business Description
  • AngioDynamics Inc - Key Facts
  • AngioDynamics Inc - Major Products and Services
  • AngioDynamics Inc Pipeline Products by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc Pipeline Products Overview
  • Acuswift
  • Acuswift Product Overview
  • Alphavac F13 10
  • Alphavac F13 10 Product Overview
  • Alphavac F14 20
  • Alphavac F14 20 Product Overview
  • Alphavac System - Infective Endocarditis
  • Alphavac System - Infective Endocarditis Product Overview
  • Alphavac System - Left Atrial Appendage Thrombus
  • Alphavac System - Left Atrial Appendage Thrombus Product Overview
  • AngioVac - Generation 4
  • AngioVac - Generation 4 Product Overview
  • AngioVac - Left Heart
  • AngioVac - Left Heart Product Overview
  • AngioVac Low Profile Catheter
  • AngioVac Low Profile Catheter Product Overview
  • AURYON Atherectomy System - CAD
  • AURYON Atherectomy System - CAD Product Overview
  • AURYON Atherectomy System - Gastrointestinal Procedures
  • AURYON Atherectomy System - Gastrointestinal Procedures Product Overview
  • AURYON Atherectomy System - Iliofemoral DVT
  • AURYON Atherectomy System - Iliofemoral DVT Product Overview
  • AURYON Atherectomy System - Lead Extraction
  • AURYON Atherectomy System - Lead Extraction Product Overview
  • AURYON Atherectomy System - Venous Disease
  • AURYON Atherectomy System - Venous Disease Product Overview
  • AURYON System - Small Vessel Thrombectomy
  • AURYON System - Small Vessel Thrombectomy Product Overview
  • Automated Fluid Management System
  • Automated Fluid Management System Product Overview
  • BioFlo PICC Line Extension
  • BioFlo PICC Line Extension Product Overview
  • BioFlo Portline Line Extension
  • BioFlo Portline Line Extension Product Overview
  • Coronary Angio Catheter
  • Coronary Angio Catheter Product Overview
  • FireFly Tip Location
  • FireFly Tip Location Product Overview
  • Inflation Device
  • Inflation Device Product Overview
  • Mechanical Thrombectomy Device
  • Mechanical Thrombectomy Device Product Overview
  • Multi-Purpose Mechanical Aspiration - F1885 PE
  • Multi-Purpose Mechanical Aspiration - F1885 PE Product Overview
  • Multi-Purpose Mechanical Aspiration Gen 2
  • Multi-Purpose Mechanical Aspiration Gen 2 Product Overview
  • NanoKnife 3.0 System - Liver Cancer
  • NanoKnife 3.0 System - Liver Cancer Product Overview
  • NanoKnife 3.0 System - Pancreatic Cancer
  • NanoKnife 3.0 System - Pancreatic Cancer Product Overview
  • NanoKnife 3.0 System - Prostate Cancer
  • NanoKnife 3.0 System - Prostate Cancer Product Overview
  • Nanoknife System - Bladder Cancer
  • Nanoknife System - Bladder Cancer Product Overview
  • NanoKnife System - Cervical Cancer
  • NanoKnife System - Cervical Cancer Product Overview
  • NanoKnife System - Head And Neck Cancer
  • NanoKnife System - Head And Neck Cancer Product Overview
  • NanoKnife System - Hepatocellular Carcinoma
  • NanoKnife System - Hepatocellular Carcinoma Product Overview
  • NanoKnife System - Lung Cancer
  • NanoKnife System - Lung Cancer Product Overview
  • NanoKnife System - Lung Cancer Clinical Trial
  • Nanoknife System - Metastatic Lymph Nodes
  • Nanoknife System - Metastatic Lymph Nodes Product Overview
  • NanoKnife System - Prostate Cancer
  • NanoKnife System - Prostate Cancer Product Overview
  • NanoKnife System - Prostate Cancer Clinical Trial
  • NanoKnife System - Rectal Cancer
  • NanoKnife System - Rectal Cancer Product Overview
  • Nanoknife System - Renal Pelvis Urothelial Neoplasms
  • Nanoknife System - Renal Pelvis Urothelial Neoplasms Product Overview
  • NanoKnife System - Stage III Pancreatic Cancer
  • NanoKnife System - Stage III Pancreatic Cancer Product Overview
  • NanoKnife System - Stage III Pancreatic Cancer Clinical Trial
  • Nanoknife System - Stomach Neoplasm
  • Nanoknife System - Stomach Neoplasm Product Overview
  • Next Gen Tumescent Delivery Device
  • Next Gen Tumescent Delivery Device Product Overview
  • Next Generation BioFlo PICC
  • Next Generation BioFlo PICC Product Overview
  • Next Generation BioFlo Port
  • Next Generation BioFlo Port Product Overview
  • Next Generation Dialysis Device
  • Next Generation Dialysis Device Product Overview
  • Next Generation Laser
  • Next Generation Laser Product Overview
  • Next Generation Radio Frequency Ablation System
  • Next Generation Radio Frequency Ablation System Product Overview
  • Non-Thermal Vein Ablation Device
  • Non-Thermal Vein Ablation Device Product Overview
  • Peripheral Vascular Drainage Line Extension
  • Peripheral Vascular Drainage Line Extension Product Overview
  • POWERWAVE
  • POWERWAVE Product Overview
  • RadiaDyne Endorectal Balloon Device
  • RadiaDyne Endorectal Balloon Device Product Overview
  • Smart Port - Dual
  • Smart Port - Dual Product Overview
  • Ultrasound-Assisted Thrombectomy System
  • Ultrasound-Assisted Thrombectomy System Product Overview
  • AngioDynamics Inc - Key Competitors
  • AngioDynamics Inc - Key Employees
  • AngioDynamics Inc - Key Employee Biographies
  • AngioDynamics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • AngioDynamics Inc, Recent Developments
  • May 21, 2024: AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System
  • May 06, 2024: AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
  • May 03, 2024: Catheter-Directed Mechanical Thrombectomy System Demonstrates Safety and Effectiveness in Patients with Pulmonary Embolism
  • Apr 16, 2024: AngioDynamics Receives Additional FDA 510(k) Clearance for AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
  • Apr 04, 2024: Angiodynamics Receives 510(K) Clearance for Alphavac F1885 System in Treatment of PE
  • Jan 23, 2024: AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
  • Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
  • Dec 07, 2023: AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
  • Aug 16, 2023: AngioDynamics’ AngioVac receives breakthrough device designation from FDA
  • Aug 03, 2023: Angiodynamics Completes Enrollment for Preserve Clinical Study
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AngioDynamics Inc Pipeline Products by Equipment Type
  • AngioDynamics Inc Pipeline Products by Indication
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc, Key Facts
  • AngioDynamics Inc, Major Products and Services
  • AngioDynamics Inc Number of Pipeline Products by Development Stage
  • AngioDynamics Inc Pipeline Products Summary by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc Ongoing Clinical Trials Summary
  • Acuswift - Product Status
  • Acuswift - Product Description
  • Alphavac F13 10 - Product Status
  • Alphavac F13 10 - Product Description
  • Alphavac F14 20 - Product Status
  • Alphavac F14 20 - Product Description
  • Alphavac System - Infective Endocarditis - Product Status
  • Alphavac System - Infective Endocarditis - Product Description
  • Alphavac System - Left Atrial Appendage Thrombus - Product Status
  • Alphavac System - Left Atrial Appendage Thrombus - Product Description
  • AngioVac - Generation 4 - Product Status
  • AngioVac - Generation 4 - Product Description
  • AngioVac - Left Heart - Product Status
  • AngioVac - Left Heart - Product Description
  • AngioVac Low Profile Catheter - Product Status
  • AngioVac Low Profile Catheter - Product Description
  • AURYON Atherectomy System - CAD - Product Status
  • AURYON Atherectomy System - CAD - Product Description
  • AURYON Atherectomy System - Gastrointestinal Procedures - Product Status
  • AURYON Atherectomy System - Gastrointestinal Procedures - Product Description
  • AURYON Atherectomy System - Iliofemoral DVT - Product Status
  • AURYON Atherectomy System - Iliofemoral DVT - Product Description
  • AURYON Atherectomy System - Lead Extraction - Product Status
  • AURYON Atherectomy System - Lead Extraction - Product Description
  • AURYON Atherectomy System - Venous Disease - Product Status
  • AURYON Atherectomy System - Venous Disease - Product Description
  • AURYON System - Small Vessel Thrombectomy - Product Status
  • AURYON System - Small Vessel Thrombectomy - Product Description
  • Automated Fluid Management System - Product Status
  • Automated Fluid Management System - Product Description
  • BioFlo PICC Line Extension - Product Status
  • BioFlo PICC Line Extension - Product Description
  • BioFlo Portline Line Extension - Product Status
  • BioFlo Portline Line Extension - Product Description
  • Coronary Angio Catheter - Product Status
  • Coronary Angio Catheter - Product Description
  • FireFly Tip Location - Product Status
  • FireFly Tip Location - Product Description
  • Inflation Device - Product Status
  • Inflation Device - Product Description
  • Mechanical Thrombectomy Device - Product Status
  • Mechanical Thrombectomy Device - Product Description
  • Multi-Purpose Mechanical Aspiration - F1885 PE - Product Status
  • Multi-Purpose Mechanical Aspiration - F1885 PE - Product Description
  • Multi-Purpose Mechanical Aspiration Gen 2 - Product Status
  • Multi-Purpose Mechanical Aspiration Gen 2 - Product Description
  • NanoKnife 3.0 System - Liver Cancer - Product Status
  • NanoKnife 3.0 System - Liver Cancer - Product Description
  • NanoKnife 3.0 System - Pancreatic Cancer - Product Status
  • NanoKnife 3.0 System - Pancreatic Cancer - Product Description
  • NanoKnife 3.0 System - Prostate Cancer - Product Status
  • NanoKnife 3.0 System - Prostate Cancer - Product Description
  • Nanoknife System - Bladder Cancer - Product Status
  • Nanoknife System - Bladder Cancer - Product Description
  • NanoKnife System - Cervical Cancer - Product Status
  • NanoKnife System - Cervical Cancer - Product Description
  • NanoKnife System - Head And Neck Cancer - Product Status
  • NanoKnife System - Head And Neck Cancer - Product Description
  • NanoKnife System - Hepatocellular Carcinoma - Product Status
  • NanoKnife System - Hepatocellular Carcinoma - Product Description
  • NanoKnife System - Lung Cancer - Product Status
  • NanoKnife System - Lung Cancer - Product Description
  • NanoKnife System - Lung Cancer - A Novel Method for Treating Lung Metastases with the Combination of Electrical Fields and Radiation Therapy: A Single-arm Pilot Study
  • Nanoknife System - Metastatic Lymph Nodes - Product Status
  • Nanoknife System - Metastatic Lymph Nodes - Product Description
  • NanoKnife System - Prostate Cancer - Product Status
  • NanoKnife System - Prostate Cancer - Product Description
  • NanoKnife System - Prostate Cancer - A Pilot Study Evaluating Safety and Efficacy of Transperineal Focal Irreversible Electroporation (IRE) of Anterior Prostate Cancer in Patients with an Intermediate Risk
  • NanoKnife System - Prostate Cancer - Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-risk Patient Population
  • NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
  • NanoKnife System - Rectal Cancer - Product Status
  • NanoKnife System - Rectal Cancer - Product Description
  • Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Status
  • Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Description
  • NanoKnife System - Stage III Pancreatic Cancer - Product Status
  • NanoKnife System - Stage III Pancreatic Cancer - Product Description
  • NanoKnife System - Stage III Pancreatic Cancer - A Phase 1 Study of Irreversible Electroporation and Pembrolizumab Immunotherapy in Locally Advanced Pancreatic Cancer
  • NanoKnife System - Stage III Pancreatic Cancer - A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
  • NanoKnife System - Stage III Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
  • NanoKnife System - Stage III Pancreatic Cancer - Multicenter Clinical Trial of Widening the Applied Range of Steep Pulse (IRE)Therapy Instrument in Pancreatic Cancer
  • NanoKnife System - Stage III Pancreatic Cancer - Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
  • NanoKnife System - Stage III Pancreatic Cancer - Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study
  • Nanoknife System - Stomach Neoplasm - Product Status
  • Nanoknife System - Stomach Neoplasm - Product Description
  • Next Gen Tumescent Delivery Device - Product Status
  • Next Gen Tumescent Delivery Device - Product Description
  • Next Generation BioFlo PICC - Product Status
  • Next Generation BioFlo PICC - Product Description
  • Next Generation BioFlo Port - Product Status
  • Next Generation BioFlo Port - Product Description
  • Next Generation Dialysis Device - Product Status
  • Next Generation Dialysis Device - Product Description
  • Next Generation Laser - Product Status
  • Next Generation Laser - Product Description
  • Next Generation Radio Frequency Ablation System - Product Status
  • Next Generation Radio Frequency Ablation System - Product Description
  • Non-Thermal Vein Ablation Device - Product Status
  • Non-Thermal Vein Ablation Device - Product Description
  • Peripheral Vascular Drainage Line Extension - Product Status
  • Peripheral Vascular Drainage Line Extension - Product Description
  • POWERWAVE - Product Status
  • POWERWAVE - Product Description
  • RadiaDyne Endorectal Balloon Device - Product Status
  • RadiaDyne Endorectal Balloon Device - Product Description
  • Smart Port - Dual - Product Status
  • Smart Port - Dual - Product Description
  • Ultrasound-Assisted Thrombectomy System - Product Status
  • Ultrasound-Assisted Thrombectomy System - Product Description
  • AngioDynamics Inc, Key Employees
  • AngioDynamics Inc, Key Employee Biographies
  • AngioDynamics Inc, Other Locations
  • AngioDynamics Inc, Subsidiaries
  • Glossary
List of Figures
  • AngioDynamics Inc Pipeline Products by Equipment Type
  • AngioDynamics Inc Pipeline Products by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cook Medical Inc
  • Terumo Medical Corp
  • Teleflex Inc
  • Total Vein Systems
  • Smiths Medical
  • Medtronic Plc
  • CR Bard Inc
  • Merit Medical Systems Inc
  • Johnson & Johnson
  • Boston Scientific Corp